MHRA Approves New Medical Cannabis Product for NHS Trial

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new cannabis-based medicinal product for inclusion in an NHS-sponsored clinical trial. The approval marks a notable step forward in the effort to expand the evidence base for medical cannabis within the NHS framework and could eventually support the case for wider reimbursement.

Details of the Approval

The product, a standardised full-spectrum cannabis extract developed for use in chronic neurological conditions, has been granted a Clinical Trial Authorisation. The trial will be conducted across multiple NHS sites and will enrol patients with conditions currently underserved by existing therapies.

The MHRA's approval follows a rigorous review of preclinical and early-phase clinical data. The regulator confirmed that the product meets required pharmaceutical quality standards and that the proposed trial protocol adequately addresses patient safety considerations.

Why This Matters

The NHS currently reimburses cannabis-based medicines only in very limited circumstances — most notably Epidyolex for treatment-resistant childhood epilepsy. The vast majority of UK patients access medical cannabis through private clinics at significant personal expense.

Successful NHS-sponsored trials are a key step towards establishing the evidence required for National Institute for Health and Care Excellence appraisal, which in turn determines NHS reimbursement eligibility. Positive trial outcomes could therefore have transformative implications for patient access.

• NHS clinical trials generate higher-quality evidence than observational data alone
• Successful outcomes could support an NHS Technology Appraisal submission to NICE
• Trial participation may allow eligible patients to access treatment at no cost
• Results expected to be published within two to three years

Current Access Options for Patients

While NHS-funded treatment remains limited, patients have access to a growing network of private specialist clinics across the UK. To explore your eligibility, visit our clinic finder or read our guide to medical cannabis products to understand which treatment types may be most appropriate for your condition.